Skip to Main Content

Two different pills reduce the risk of ovarian cancer coming back after surgery and chemotherapy, according to studies presented at the annual meeting of the European Society for Medical Oncology in Barcelona Saturday.

The results represent a step forward in treating a cancer that is diagnosed in 28,000 women annually in the U.S. and kills 14,000 women a year. Currently, women are treated with surgery to remove their tumors, followed with a type of chemotherapy. But in 85% of cases, the cancer comes back.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • I am a recurrent ovarian cancer patient and would like a copy of the article without having to pay for a subscription if possible, please. Thank you.

Comments are closed.